Welcome to LookChem.com Sign In|Join Free
  • or
4-(dibenzofuran-4-group) phenylboric acid, also known as 4-(dibenzofuran-4-yl)phenylboric acid, is a chemical compound with the molecular formula C18H13BO3. It features a phenylboronic acid core with a dibenzofuran group attached to the phenyl ring, which endows it with unique chemical and biological properties. 4-(dibenzofuran-4-group) phenylboric acid is valuable in the field of organic chemistry and medicinal research due to its potential applications in the development of novel materials and in the treatment of various diseases.

796071-96-0

Post Buying Request

796071-96-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

796071-96-0 Usage

Uses

Used in Organic Synthesis:
4-(dibenzofuran-4-group) phenylboric acid is used as a reagent in organic synthesis for its unique chemical properties, enabling the creation of complex organic molecules and contributing to the advancement of chemical research.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 4-(dibenzofuran-4-group) phenylboric acid is used as a component in the development of new drugs. Its chemical structure allows for the design of molecules with specific therapeutic effects, potentially leading to the creation of novel treatments for various diseases.
Used in Agrochemicals:
4-(dibenzofuran-4-group) phenylboric acid is also utilized in the agrochemical sector, where it serves as a component in the formulation of pesticides and other agricultural chemicals. Its properties may contribute to the development of more effective and environmentally friendly products.
Used in Material Science:
4-(dibenzofuran-4-group) phenylboric acid has been studied for its potential applications in the development of novel materials, where its unique structure and properties could lead to the creation of innovative materials with specific characteristics for various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 796071-96-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,6,0,7 and 1 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 796071-96:
(8*7)+(7*9)+(6*6)+(5*0)+(4*7)+(3*1)+(2*9)+(1*6)=210
210 % 10 = 0
So 796071-96-0 is a valid CAS Registry Number.

796071-96-0Relevant academic research and scientific papers

Organic compounds and the electronic components and electronic devices in which they are used

-

Paragraph 0205-0208; 0211, (2022/04/06)

The present application relates to an organic compound comprising an electron transport group and a conjugate fused heteroaromatic ring in structure, which may be used in the functional layer of an organic electroluminescent device. The organic compounds of the present application for organic electroluminescent devices may improve the luminous efficiency and service life of the device.

ORGANIC COMPOUNDS, ORGANIC LIGHT EMITTING DIODE AND ORGNIC LIGHT EMITTING DEVICE HAVING THE COMPOUNDS

-

Paragraph 0149; 0153-0155, (2019/10/08)

The present invention relates to an organic compound having a dibenzophenazine moiety connected to a hetero-aromatic moiety via a linker. The organic compound has a hetero-aromatic moiety with desirable n-type properties and thus minimizes exciton quenching due to an interaction between a triplet exciton of a dopant and a hole-polaron formed in proximity. Accordingly, the organic compound may prevent the service lifetime of a light-emitting diode device from decreasing due to electro oxidation and photo oxidation. Further, the organic compound due to a dibenzophenazine moiety with a stable structure, has excellent thermal stability; and does not suffer a decrease in energy band gap and triplet excited state energy level (T_1), thereby improving luminance efficiency. Thus, the organic compound may be used in combination with, for example, a delayed fluorescence dopant emitting a blue light, to be used as a host of a light-emitting material layer. The organic compound may be applied to an organic light-emitting diode, an organic light-emitting device, and the like, to improve luminance efficiency and device lifetime thereof.COPYRIGHT KIPO 2019

HETEROCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME

-

, (2016/10/09)

The present invention discloses a novel heterocyclic compound of Formula (1) and an organic electroluminescent device using the same, in which variables are as described herein. The heterocyclic compound of Formula (1) is present in the emitting layer as

A including anthracene apperception compound and its preparation method and an organic light emitting device (by machine translation)

-

Paragraph 0150; 0151; 0190; 0191; 0192; 0195, (2017/04/22)

The invention provides a including anthracene apperception compound, of formula (I) as shown in the structure. The invention by modifying the structure of the anthracene compound, so that the formula (I) indicated by the anthracene compound of the organic

NOVEL COMPOUNDS FOR ORGANIC ELECTRONIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME

-

, (2012/11/06)

The present invention relates to a novel compound and an organic electroluminescent device containing the same. The compound according to the present invention has an advantage in manufacturing an organic electroluminescent device which has high luminous efficiency and a long operation lifetime.

AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT

-

Page/Page column 27; 37, (2012/01/11)

Provided are a long-lifetime organic electroluminescence device which can be fabricated in an improved yield owing to suppressed crystallization of molecules, and an aromatic amine derivative that realizes the device, i.e. , a novel aromatic amine derivative having a specific structure. Specifically provided are an organic electroluminescence device, including an organic thin film layer formed of one or more layers including at least a light emitting layer, the organic thin film layer being interposed between a cathode and an anode, and an aromatic amine derivative for at least one layer of the organic thin film layer, in particular, a hole transporting layer, the derivative having at least one such structure that a substituent in which two or more specific heterocycles are linked to each other, in particular, a substituent in which two or more specific heterocycles are linked through an aryl group is bonded to an amine through an aryl group.

PHENYL SUBSTITUTED CARBOXYLIC ACIDS

-

Page/Page column 85-86, (2008/06/13)

Disclosed are compounds and pharmaceutically acceptable salts of formula (A): which are useful in the treatment of metabolic disorders related to insulin resistance, leptin resistance, or hyperglycemia. Compounds of the invention include inhibitors of Protein tyrosine phosphatases, in particular Protein tyrosine phosphatase-1B (PTP-1B), that are useful in the treatment of diabetes and other PTP mediated diseases, such as cancer, neurodegenerative diseases and the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.

SUBSTITUTED AMINO CARBOXYLIC ACIDS

-

Page/Page column 197-198, (2008/06/13)

Disclosed are compounds and pharmaceutically acceptable salts of formula (I): which are useful in the treatment of metabolic disorders related to insulin resistance, leptin resistance, or hyperglycemia. Compounds of the invention include inhibitors of Protein tyrosine phosphatases, in particular Protein tyrosine phosphatase-1B (PTP-1B), that are useful in the treatment of diabetes and other PTP mediated diseases, such as cancer, neurodegenerative diseases and the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.

Heterocycle substituted carboxylic acids

-

Page/Page column 25, (2010/11/08)

The present invention relates to compounds and pharmaceutically acceptable salts of formula (I): which are useful in the treatment of metabolic disorders related to insulin resistance, leptin resistance, or hyperglycemia. Compounds of the invention includ

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 796071-96-0